Anonymous
Guest
Anonymous
Guest
Sure Onglyza is growing, from almost nothing.
Revenue from Januvia for diabetes rose 41 percent to $846 million in the recent quarter.
Revenue from Januvia for diabetes rose 41 percent to $846 million in the recent quarter.